Skip to main content Skip to search Skip to main navigation

What information should be included in the validation plan?

The validation plan should ensure the targeted planning of experimental investigations, the identification of the relevant performance parameters and acceptance criteria, and also describe and justify the use of existing knowledge and data, e.g. from test method development. For better traceability and for future similar validations, performance parameters, acceptance criteria and experimental design should be sufficiently explained and justified.

[GMP Compliance Adviser, 14. D]


 

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: New Q&A on Product Lifecycle Management (PLCM)

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.
Read more
EMA: New Q&A for Co-Processed Excipients

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

Read more
What is the Data Lifecycle?

What is the Data Lifecycle?

Here's the answer:
Read more
Previous
Next